Search by Drug Name or NDC

    NDC 00173-0562-00 AMERGE 2.5 mg/1 Details

    AMERGE 2.5 mg/1

    AMERGE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is NARATRIPTAN HYDROCHLORIDE.

    Product Information

    NDC 00173-0562
    Product ID 0173-0562_8c301e33-442e-48b9-9af9-c3afd57fa077
    Associated GPIs 67406050100320
    GCN Sequence Number 031492
    GCN Sequence Number Description naratriptan HCl TABLET 2.5 MG ORAL
    HIC3 H3F
    HIC3 Description ANTIMIGRAINE PREPARATIONS
    GCN 81111
    HICL Sequence Number 013266
    HICL Sequence Number Description NARATRIPTAN HCL
    Brand/Generic Brand
    Proprietary Name AMERGE
    Proprietary Name Suffix n/a
    Non-Proprietary Name naratriptan hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name NARATRIPTAN HYDROCHLORIDE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020763
    Listing Certified Through 2022-12-31

    Package

    NDC 00173-0562-00 (00173056200)

    NDC Package Code 0173-0562-00
    Billing NDC 00173056200
    Package 9 TABLET, FILM COATED in 1 BLISTER PACK (0173-0562-00)
    Marketing Start Date 1998-02-26
    NDC Exclude Flag N
    Pricing Information N/A